Brief Report on the Efficacy of Nivolumab in Patients With Previously Treated Advanced Large-Cell Neuroendocrine Cancer of the Lung

INTRODUCTION: The optimal management of large cell neuroendocrine cancer of the lung (LCNEC) is unclear, and data regarding anti–programmed cell death protein 1 (PD-1) antibodies are scarce. This study reports the clinical efficacy of a PD-1 inhibitor in patients with advanced LCNEC. METHODS: All pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Agar, Camille, Geier, Margaux, Léveiller, Guillaume, Lamy, Régine, Bizec, Jean-Louis, Tiercin, Marie, Bernier, Cyril, Robinet, Gilles, Léna, Hervé, Ricordel, Charles, Corre, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474479/
https://www.ncbi.nlm.nih.gov/pubmed/34590004
http://dx.doi.org/10.1016/j.jtocrr.2020.100129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474479/
https://www.ncbi.nlm.nih.gov/pubmed/34590004
http://dx.doi.org/10.1016/j.jtocrr.2020.100129

Ejemplares similares